cliffwatch

amlodipine benzoate · Azurity · NDA 211340

Katerzia

Earliest generic entry, as listed
11 Apr 2039

Blocked by patent: US 10799453.

Listed patents · 19 unexpired

PatentClaimsExpires
US 10799453product11 Apr 2039
US 10695329product16 Oct 2037
US 10894039use U-36 Oct 2037
US 10894039use U-1856 Oct 2037
US 10952998product6 Oct 2037
US 10959991use U-396 Oct 2037
US 10959991use U-1586 Oct 2037
US 11364230product6 Oct 2037
US 11471409use U-34486 Oct 2037
US 11471409use U-34476 Oct 2037
US 11484498product6 Oct 2037
US 11701326product6 Oct 2037
US 11918685use U-34486 Oct 2037
US 11918685use U-34476 Oct 2037
US 12053461product6 Oct 2037
US 12336984use U-34486 Oct 2037
US 12336984use U-34476 Oct 2037
US 12383498product6 Oct 2037
US 12721843product6 Oct 2037

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 1

NDA · productFormStrengthListed expiry
211340 · 001 · RLDsuspension, oralEQ 1MG BASE/ML11 Apr 2039